Company intelligence / Profile preview

Lake Immunogenics

Ontario, New York, United States

Ownership: Private
Employees: ~15
Development stage: Other

Overview

Lake Immunogenics is a biotechnology company specializing in the production of high-quality polyclonal antibodies and animal-derived biological products. Founded in 1989 and based in Ontario, New York, the company provides custom antibody development services, including immunization, collection, and purification. Their product catalog includes a wide range of animal sera, plasma, and red blood cells used primarily in research and diagnostic applications. Lake Immunogenics operates a USDA-registered facility, ensuring compliance with rigorous standards for animal welfare and product consistency. The company serves the global life sciences community, supporting academic research, pharmaceutical development, and diagnostic manufacturing.

Modalities: Antibody
Industry: Chemicals & Materials

Beyond the preview

Go deeper on Lake Immunogenics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lake Immunogenics.

Explore the full profile